Why the study?
Does catheter ablation prevent recurrence of ventricular tachycardia in patients with drug-refractory VT who are not candidates for surgery or ICD?
Does catheter ablation prevent recurrence of ventricular tachycardia in patients with drug-refractory VT who are not candidates for surgery or ICD?
Catheter ablation using DC or RF energy can prevent ventricular tachycardia recurrence in a substantial proportion of patients with drug-refractory VT who are not candidates for surgery or ICD.
Answers are grounded in this paper and cite their sources.
May support ablation for VT control in drug-refractory cases ineligible for ICD; leaves open randomized confirmation of benefit.
Catheter ablation of ventricular tachycardias was performed in a total of 80 patients whose tachycardias were considered as drug refractory and who were not considered to be candidates for antitachycardic surgery or implantation of an automatic cardioverter defibrillator. After careful endocardial catheter mapping including pacing interventions, either direct-current (DC) (n = 61) or radiofrequency current (RF) (n = 13) or both (n = 6) were applied of the "site of origin" of ventricular tachycardia or the "zone of slow conduction". 42 of 51 patients with coronary heart disease were discharged; ventricular tachycardia recurred in 8 cases, and 2 patients died suddenly. In the remaining 32 patients, there were no recurrences of ventricular tachycardia during a mean follow-up period of 12 month. Three patients died perioperatively. In 21 of 29 patients without coronary artery disease, no recurrences of ventricular tachycardia were observed (mean duration of follow-up 17 months) whereas 8 cases had a recurrence of ventricular tachycardia.
No takes yet. Share an insight, caveat, or question.
Borggrefe et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: